73
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

A Simplified Method for the Estimation of Amiodarone Hydrochloride by Reverse‐Phase High Performance Liquid Chromatography

&
Pages 1315-1326 | Received 20 Jul 2002, Accepted 23 Dec 2002, Published online: 06 Feb 2007
 

Abstract

Amiodarone is a class III anti‐arrhythmic agent and one of the most powerful drugs used in the treatment of ventricular and supraventricular tachycardias. The drug is available in the market as tablet and injectable formulations. In this study, a repeatable reverse‐phase high performance liquid chromatographic method for quality control purposes only has been developed for the estimation of amiodarone hydrochloride in a dosage form. A C‐8 column was used in the study. The mobile phase consisted of methanol, water, and acetic acid in a 95:4:1 ratio and the pH adjusted to 4.0 with aqueous ammonia. Nortriptyline was chosen as the internal standard and a flow rate of 1.5 mL/min was used with the buffer and water in 98:2 concentrations. The retention time for amiodarone hydrochloride and nortriptyline was approximately 3.5 and 1.8 min, respectively. The analytical method was found to be linear and stability indicating with the relative standard deviation within and between days being 2.48% and 3.26%, respectively. The LOQ and LOD were found to be 3.12 mcg and 0.936 mcg, respectively.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.